Ruben Kalra
Interventional Pain Medicine · Pleasant Hill, CANPI 1245228766
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Nevro Corp. at 41.0% of the total. Reporting peaked in 2019 at $343 and has fallen 75.3% since, to $85 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in CA, where the typical reported total is $3,134.
Across 35 payments — averaging $37.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$532
- Painteq LLC$191
- Abbott$130
- Saluda Medical Americas, Inc.$104
- Boston Scientific$96
- SPR Therapeutics, Inc$90
- plus $155 from 5 others
What the payments were for
- Food & beverage$1,297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 13 | $532 |
| Painteq LLC | 2 | $191 |
| Abbott | 4 | $130 |
| Saluda Medical Americas, Inc. | 4 | $104 |
| Boston Scientific | 2 | $96 |
| SPR Therapeutics, Inc | 3 | $90 |
| Medtronic(2 entities) | 3 | $64 |
| Neuronetics, Inc. | 1 | $30 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $18 |
| Nalu Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,297 in reported general payments places this provider in the 30th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $1,829 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $1,532 |
| Buprenorphine Hcl | 14 | $1,348 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $1,215 |
| Lidocaine | 17 | $1,000 |
| Morphine Sulfate ErMorphine Sulfate | 19 | $516 |
| Baclofen | 28 | $354 |
| Gabapentin | 29 | $291 |
| Pregabalin | 11 | $247 |
| Cyclobenzaprine Hcl | 24 | $166 |
| Tizanidine Hcl | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Pleasant Hill
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.